Cybin Inc. (NEO:CYBN | NYSE American:CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics®, today announced an upcoming...
The article Microdose Announces Sponsors For Wonderland 2022 was originally published on Microdose. The leader in the business of psychedelics, Microdose...
Pune, Oct. 27, 2022 (GLOBE NEWSWIRE) -- "Psychedelic Drugs Market" Insights 2022 By Types, Applications, Regions and Forecast to 2028. The global Psychedelic...
Cybin Inc. (NEO:CYBN | NYSE American:CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics®”, today announced the...
Psychedelic medicines company Beckley Psytech has reached an agreement to acquire its rival Eleusis Therapeutics, in alignment with The post Consolidation...
The article Top 5 Psychedelic Clinical Trials in 2022 was originally published on Microdose. In order for psychedelic medicines to be legalized in a doctor-prescribed...
Although the Psychedelic Invest index had been performing well since the lows in May, September turned out to be a bad month for the market with...
Cybin Inc. (NEO:CYBN | NYSE AMERICAN:CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics®, and The Chopra Foundation...
ALTRD.TV, the streaming network for progressive culture, released the trailer for its new upcoming series Open Minds: Exploring Psychedelic Medicine,...
Source: Dr. Elemer Piros 10/06/2022 Read to learn why ROTH Capital Partners gave Atai Life Sciences NV a Buy rating and a target price 10...